|
1
|
Pappa KI, Polyzos A, Jacob-Hirsch J,
Amariglio N, Vlachos GD, Loutradis D and Anagnou NP: Profiling of
discrete gynecological cancers reveals novel transcriptional
modules and common features shared by other cancer types and
embryonic stem cells. PLoS One. 10:e01422292015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mohankumar K, Pajaniradje S, Sridharan S,
Singh VK, Ronsard L, Banerjea AC, Benson CS, Coumar MS and
Rajagopalan R: Mechanism of apoptotic induction in human breast
cancer cell, MCF-7, by an analog of curcumin in comparison with
curcumin-an in vitro and in silico approach. Chem Biol Interact.
210:51–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
US Cancer Statistics Working Group, .
United States Cancer Statistics: 1999–2011 incidence and mortality
web-based report. U.S. Department of Health and Human Services,
Center for Disease Control and Prevention and National Cancer
Institute; Atlanta, GA: 2014, https://www.cdc.gov/uscs3–March. 2015
|
|
4
|
Yang Y, Han L, Yuan Y, Li J, Hei N and
Liang H: Gene co-expression network analysis reveals common
system-level properties of prognostic genes across cancer types.
Nat Commun. 5:32312014.PubMed/NCBI
|
|
5
|
Peng L, Bian XW, Li DK, Xu C, Wang GM, Xia
QY and Xiong Q: Large-scale RNA-seq transcriptome analysis of 4043
cancers and 548 normal tissue controls across 12 TCGA cancer types.
Sci Rep. 5:134132015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martinez E, Yoshihara K, Kim H, Mills GM,
Treviño V and Verhaak RG: Comparison of gene expression patterns
across 12 tumor types identifies a cancer supercluster
characterized by TP53 mutations and cell cycle defects. Oncogene.
34:2732–2740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alberghina L, Höfer T and Vanoni M:
Molecular networks and system-level properties. J Biotechnol.
144:224–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alisoltani A, Fallahi H, Ebrahimi M,
Ebrahimi M and Ebrahimie E: Prediction of potential cancer-risk
regions based on transcriptome data: towards a comprehensive view.
PLoS One. 9:e963202014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mine KL, Shulzhenko N, Yambartsev A,
Rochman M, Sanson GF, Lando M, Varma S, Skinner J, Volfovsky N,
Deng T, et al: Gene network reconstruction reveals cell cycle and
antiviral genes as major drivers of cervical cancer. Nat Commun.
4:18062013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hoadley KA, Yau C, Wolf DM, Cherniack AD,
Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov
V, et al: Multiplatform analysis of 12 cancer types reveals
molecular classification within and across tissues of origin. Cell.
158:929–944. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fruzangohar M, Ebrahimie E, Ogunniyi AD,
Mahdi LK, Paton JC and Adelson DL: Correction: Comparative GO: A
web application for comparative gene ontology and gene
ontology-based gene selection in bacteria. PLoS One.
10:e01255372015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu J, Allen W, Xia A, Ma Z and Qi X:
Identification of biomarkers in breast cancer by gene expression
profiling using human tissues. Genom Data. 2:299–301. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bonome T, Levine DA, Shih J, Randonovich
M, Pise-Masison CA, Bogomolniy F, Ozbun L, Brady J, Barrett JC,
Boyd J and Birrer MJ: A gene signature predicting for survival in
suboptimally debulked patients with ovarian cancer. Cancer Res.
68:5478–5486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of affymetrix genechip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Team RCore, . R: A language and
environment for statistical computing. Vienna, Austria: R
Foundation for Statistical Computing; pp. 3–36. 2014, http://www.r-project.org/
|
|
17
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. Journal of the Royal Statistical Society. J R
Statics Soc B. 1–300. 1995.
|
|
18
|
Von Mering C, Huynen M, Jaeggi D, Schmidt
S, Bork P and Snel B: STRING: A database of predicted functional
associations between proteins. Nucleic Acids Res. 31:258–261. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Duncan D, Shi Z and Zhang B:
Web-based gene set analysis toolkit (WebGestalt): Update 2013.
Nucleic Acids Res. 41:W77–W83. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dar AA, Goff LW, Majid S, Berlin J and
El-Rifai W: Aurora kinase inhibitors-rising stars in cancer
therapeutics? Mol Cancer Ther. 9:268–278. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carvajal RD, Tse A and Schwartz GK: Aurora
kinases: New targets for cancer therapy. Clin Cancer Res.
12:6869–75. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xia LP, Zhou FF, Yang MT and Liu Q: Roles
of Aurora-A in tumorigenesis and prognosis of breast cancer. Ai
Zheng. 28:668–672. 2009.(In Chinese). PubMed/NCBI
|
|
26
|
Cox DG, Hankinson SE and Hunter DJ:
Polymorphisms of the AURKA (STK15/Aurora Kinase) gene and breast
cancer risk (United States). Cancer Causes Control. 17:81–83. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang LY, He CY, Chen XH, Su LP, Liu BY and
Zhang H: Aurora kinase A revives dormant laryngeal squamous cell
carcinoma cells via FAK/PI3K/Akt pathway activation. Oncotarget.
7:48346–48359. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lo Iacono ML, Monica V, Saviozzi S, Ceppi
P, Bracco E, Papotti M and Scagliotti GV: Aurora Kinase A
expression is associated with lung cancer histological-subtypes and
with tumor de-differentiation. J Transl Med. 9:1002011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Staff S, Isola J, Jumppanen M and Tanner
M: Aurora-A gene is frequently amplified in basal-like breast
cancer. Oncol Rep. 23:307–312. 2010.PubMed/NCBI
|
|
30
|
Zou Z, Yuan Z, Zhang Q, Long Z, Chen J,
Tang Z, Zhu Y, Chen S, Xu J, Yan M, et al: Aurora kinase A
inhibition-induced autophagy triggers drug resistance in breast
cancer cells. Autophagy. 8:1798–1810. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ouchi M, Fujiuchi N, Sasai K, Katayama H,
Minamishima YA, Ongusaha PP, Deng C, Sen S, Lee SW and Ouchi T:
BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M
transition. J Biol Chem. 279:19643–19648. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tanaka T, Kimura M, Matsunaga K, Fukada D,
Mori H and Okano Y: Centrosomal kinase AIK1 is overexpressed in
invasive ductal carcinoma of the breast. Cancer Res. 59:2041–2044.
1999.PubMed/NCBI
|
|
33
|
Miyoshi Y, Iwao K, Egawa C and Noguchi S:
Association of centrosomal kinase STK15/BTAK mRNA expression with
chromosomal instability in human breast cancers. Int J Cancer.
92:370–373. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nadler Y, Camp RL, Schwartz C, Rimm DL,
Kluger HM and Kluger Y: Expression of Aurora A (but not Aurora B)
is predictive of survival in breast cancer. Clin Cancer Res.
14:4455–4462. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Twu NF, Yuan CC, Yen MS, Lai CR, Chao KC,
Wang PH, Wu HH and Chen YJ: Expression of Aurora kinase A and B in
normal and malignant cervical tissue: High Aurora A kinase
expression in squamous cervical cancer. Eur J Obstet Gynecol Reprod
Biol. 142:57–63. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gabrielli B, Bokhari F, Ranall MV, Oo ZY,
Stevenson AJ, Wang W, Murrell M, Shaikh M, Fallaha S, Clarke D, et
al: Aurora A is critical for survival in HPV-transformed cervical
cancer. Mol Cancer Ther. 14:2753–2761. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Campos SM and Ghosh S: A current review of
targeted therapeutics for ovarian cancer. J Oncology.
2010:1493622010. View Article : Google Scholar
|
|
38
|
Do TV, Xiao F, Bickel LE, Klein-Szanto AJ,
Pathak HB, Hua X, Howe C, O'Brien SW, Maglaty M, Ecsedy JA, et al:
Aurora kinase A mediates epithelial ovarian cancer cell migration
and adhesion. Oncogene. 33:539–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Katsha A, Belkhiri A, Goff L and El-Rifai
W: Aurora kinase A in gastrointestinal cancers: Time to target. Mol
Cancer. 14:1062015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kurai M, Shiozawa T, Shih HC, Miyamoto T,
Feng YZ, Kashima H, Suzuki A and Konishi I: Expression of Aurora
kinases A and B in normal, hyperplastic and malignant human
endometrium: Aurora B as a predictor for poor prognosis in
endometrial carcinoma. Hum Pathol. 36:1281–1288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Moreno-Bueno G, Sánchez-Estévez C, Cassia
R, Rodríguez-Perales S, Díaz-Uriarte R, Domínguez O, Hardisson D,
Andujar M, Prat J, Matias-Guiu X, et al: Differential gene
expression profile in endometrioid and nonendometrioid endometrial
carcinoma STK15 is frequently overexpressed and amplified in
nonendometrioid carcinomas. Cancer Res. 63:5697–5702.
2003.PubMed/NCBI
|
|
42
|
van de Nieuwenhof HP, van der Avoort IA
and de Hullu JA: Review of squamous premalignant vulvar lesions.
Crit Rev Oncol Hematol. 68:131–156. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ueda Y, Enomoto T and Kimura T, Yoshino K,
Fujita M and Kimura T: Two distinct pathways to development of
squamous cell carcinoma of the vulva. J Skin Cancer.
2011:9512502011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Miki H, Setou M, Kaneshiro K and Hirokawa
N: All kinesin superfamily protein, KIF, genes in mouse and human.
Proc Natl Acad Sci USA. 98:pp. 7004–7011. 2001; View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tomita Y, Yuno A, Tsukamoto H, Senju S,
Kuroda Y, Hirayama M, Irie A, Kawahara K, Yatsuda J, Hamada A, et
al: Identification of promiscuous KIF20A long peptides bearing both
CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity
in patients with malignant tumor. Clin Cancer Res. 19:4508–4520.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Imai K, Hirata S, Irie A, Senju S, Ikuta
Y, Yokomine K, Harao M, Inoue M, Tomita Y, Tsunoda T, et al:
Identification of HLA-A2-restricted CTL epitopes of a novel
tumour-associated antigen, KIF20A, overexpressed in pancreatic
cancer. Br J Cancer. 104:300–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yamashita J, Fukushima S, Jinnin M, Honda
N, Makino K, Sakai K, Masuguchi S, Inoue Y and Ihn H: Kinesin
family member 20A is a novel melanoma-associated antigen. Acta Derm
Venereol. 92:593–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Claerhout S, Lim JY, Choi W, Park YY, Kim
K, Kim SB, Lee JS, Mills GB and Cho JY: Gene expression signature
analysis identifies vorinostat as a candidate therapy for gastric
cancer. PLoS One. 6:e246622011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Groth-Pedersen L, Aits S, Corcelle-Termeau
E, Petersen NH, Nylandsted J and Jäättelä M: Identification of
cytoskeleton-associated proteins essential for lysosomal stability
and survival of human cancer cells. PloS one. 7:e453812012.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chou WC, Cheng AL, Brotto M and Chuang CY:
Visual gene-network analysis reveals the cancer gene co-expression
in human endometrial cancer. BMC genomics. 15:3002014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Marivin A, Berthelet J, Plenchette S and
Dubrez L: The inhibitor of apoptosis (IAPs) in adaptive response to
cellular stress. Cells. 1:711–737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sawyers C: Targeted cancer therapy.
Nature. 432:294–297. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ghaffari K, Hashemi M, Ebrahimi E and
Shirkoohi R: birc5 genomic copy number variation in early-onset
breast cancer. Iran Biomed J. 20:241–245. 2016.PubMed/NCBI
|
|
54
|
Boidot R, Vegran F, Jacob D, Chevrier S,
Gangneux N, Taboureau J, Oudin C, Rainville V, Mercier L and
Lizard-Nacol S: The expression of BIRC5 is correlated with loss of
specific chromosomal regions in breast carcinomas. Genes,
Chromosomes Cancer. 47:299–308. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhou XL and Wang M: Expression levels of
survivin, Bcl-2 and KAI1 proteins in cervical cancer and their
correlation with metastasis. Genet Mol Res. 14:17059–17067. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ferrandina G, Legge F, Martinelli E,
Ranelletti FO, Zannoni GF, Lauriola L, Gessi M, Gallotta V and
Scambia G: Survivin expression in ovarian cancer and its
correlation with clinico-pathological, surgical and
apoptosis-related parameters. Br J Cancer. 92:271–277. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zahedi P, Aminimoghaddam S, Sayahpour FA,
Haghpanah V, Amiri P, Fereidoni F, Mahrampour E, Larijani B,
Tavakkoly-Bazzaz J and Amoli MM: Association of survivin gene
polymorphism with endometrial cancer. Int J Gynecol Cancer.
22:35–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wellenhofer A and Brustmann H: Expression
of human telomerase reverse transcriptase in vulvar intraepithelial
neoplasia and squamous cell carcinoma: An immunohistochemical study
with survivin and p53. Arch Pathol Lab Med. 136:1359–1365. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen X, Thiaville MM, Chen L, Stoeck A,
Xuan J, Gao M, Shih IeM and Wang TL: Defining NOTCH3 target genes
in ovarian cancer. Cancer Res. 72:2294–2303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Smalley M, Piggott L and Clarkson R:
Breast cancer stem cells: Obstacles to therapy. Cancer Lett.
338:57–62. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Luo Y, Wu Y, Peng Y, Liu X, Bie J and Li
S: Systematic analysis to identify a key role of CDK1 in mediating
gene interaction networks in cervical cancer development. Ir J Med
Sci. 185:231–239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Risinger JI, Allard J, Chandran U, Day R,
Chandramouli GV, Miller C, Zahn C, Oliver J, Litzi T, Marcus C, et
al: Gene expression analysis of early stage endometrial cancers
reveals unique transcripts associated with grade and histology but
not depth of invasion. Front Oncol. 3:1392013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Katayama H and Sen S: Aurora kinase
inhibitors as anticancer molecules. Biochim Biophy Acta.
1799:829–839. 2010. View Article : Google Scholar
|
|
64
|
Lai CH, Tseng JT, Lee YC, Chen YJ, Lee JC,
Lin BW, Huang TC, Liu YW, Leu TH, Liu YW, et al: Translational
up-regulation of Aurora-A in EGFR-overexpressed cancer. J Cell Mol
Med. 14:1520–1531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Sun C, Chan F, Briassouli P and
Linardopoulos S: Aurora kinase inhibition downregulates NF-κB and
sensitises tumour cells to chemotherapeutic agents. Biochem Biophys
Res Commun. 352:220–225. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lim KH, Brady DC, Kashatus DF, Ancrile BB,
Der CJ, Cox AD and Counter CM: Aurora-A phosphorylates, activates
and relocalizes the small GTPase RalA. Mol Cell Biol. 30:508–523.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Nilsson JA and Cleveland JL: Myc pathways
provoking cell suicide and cancer. Oncogene. 22:9007–9021. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Cole MD: MYC association with cancer risk
and a new model of MYC-mediated repression. Cold Spring Harb
Perspect Med. 4:a0143162014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
D'Assoro AB, Liu T, Quatraro C, Amato A,
Opyrchal M, Leontovich A, Ikeda Y, Ohmine S, Lingle W, Suman V, et
al: The mitotic kinase Aurora-a promotes distant metastases by
inducing epithelial-to-mesenchymal transition in ERα(+) breast
cancer cells. Oncogene. 33:599–610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Opyrchal M, Sangameswaran KD, Khoury T,
Boland P, Galanis E and Haddad TC: Aurora Kinase inhibitors in
breast cancer treatment. American Journal of Hematology/Oncology.
11:2015.
|
|
71
|
Zhang L and Zhang S: ZM447439, the Aurora
kinase B inhibitor, suppresses the growth of cervical cancer SiHa
cells and enhances the chemosensitivity to cisplatin. J Obstet
Gynaecol Res. 37:591–600. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Do TV, Xiao F, Bickel LE, Klein-Szanto AJ,
Pathak HB, Hua X, Howe C, O'Brien SW, Maglaty M, Ecsedy JA, et al:
Aurora kinase A mediates epithelial ovarian cancer cell migration
and adhesion. Oncogene. 33:539–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Umene K, Yanokura M, Banno K, Irie H,
Adachi M, Iida M, Nakamura K, Nogami Y, Masuda K, Kobayashi Y, et
al: Aurora kinase A has a significant role as a therapeutic target
and clinical biomarker in endometrial cancer. Int J Oncol.
46:1498–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
